Large-scale infrastructure projects, interconnection schemes, and renewable energy developments continue to shape the ...
DENVER--(BUSINESS WIRE)--VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic collaboration will support ...
Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic ...
This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...
The advent of multiomic approaches has significantly improved early cancer detection by integrating diverse molecular data to gain a more complete understanding of disease processes. While advances in ...
Gone are the days when oncologists reacted to a cancer diagnosis by using the few drugs we had and hoping for the best. We have evolved from being reactive to proactive, primarily due to advances in ...
Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...
TAIPEI, Nov. 28, 2025 /PRNewswire/ -- Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results